Cannabis myths miss in both directions. Some overstate the risks, like the old warning that weed kills brain cells. Others wave away real ones, such as cannabis use disorder or the link between heavy, high-potency use and psychosis. Here are five common myths, each with where it came from, why it stuck, what the research shows and a fair verdict.
Why cannabis myths spread
For decades, much of what people heard about cannabis came from two places: anti-drug campaigns and personal stories. Both favor simple messages, and neither is a good stand-in for careful research.
The products have changed, too. In illegal cannabis seized by law enforcement, THC potency climbed from about 4% in 1995 to about 16% in 2022, as reported by NIDA, the National Institute on Drug Abuse. A claim that seemed to hold for older, weaker cannabis may not fit what's on shelves today.
Research itself can be easy to misread. Many studies show that two things tend to travel together, such as heavy use and a health problem, without proving that one causes the other. Headlines rarely make that distinction, and myths grow in the gap. Legalization adds a newer myth of its own: that anything sold legally to adults must be harmless.
For each myth below, we look at four things:
- Where it came from: the origin of the claim.
- Why it stuck: what keeps it in circulation.
- What research shows: the key studies, with their limits.
- Verdict: a plain call on what's overstated and what's real.
Myth 1: "Weed kills brain cells"
Where it came from: This is a long-running line in anti-drug messaging. It's short, it's scary and it's easy to repeat.
Why it stuck: Forgetfulness while high is a familiar joke, so lasting damage feels like a short leap. The phrase also skips the hard part, which is measuring real effects over years.
What research shows: The serious questions are narrower than "brain cells," and most involve teens and heavy use. NIDA notes that adolescence is an important period of brain development. It also links regular, heavy use in the teen years to effects on working memory and processing speed.
Long-term studies point in different directions. New Zealand's Dunedin study followed 1,037 people from birth to age 38. Persistent cannabis use was linked to a decline in test performance, concentrated among people who started as teens, and quitting didn't fully restore it in that group. People who knew the participants well also reported noticing more cognitive problems in persistent users.
A 2016 study of two twin samples found something different. Teens who used cannabis didn't show significantly more IQ decline than their twin siblings who didn't. The authors suggested that family factors shaping both cannabis use and test scores may explain the drop, rather than cannabis itself.
The bigger concern is psychosis. A 2019 study compared 901 people with a first episode of psychosis to 1,237 people without one, at 11 sites in Europe and Brazil. Daily cannabis use was linked to about three times the odds of a psychotic disorder, compared with never using. Daily use of high-potency cannabis (10% THC or more) was linked to nearly five times the odds.
The same study found that sites where daily use and high-potency products were more common also had higher rates of psychotic disorder. Assuming cannabis was a cause, the authors estimated that about 12% of first-episode cases across all 11 sites were tied to high-potency cannabis. In London the estimate was about 30%, and in Amsterdam about 50%.
That is an association, not proof of cause. NIDA adds that the link between heavy cannabis use and schizophrenia has been found to be especially strong in young males.
Verdict: Overstated as a slogan, real as a warning. Heavy use that starts young, and daily use of strong products, carry risks worth taking seriously.
Myth 2: "Cannabis is a gateway drug"
Where it came from: People who use other illegal drugs often tried cannabis first. NIDA notes that cannabis is typically one of the first substances people encounter, along with alcohol and tobacco.
Why it stuck: When one thing comes before another, it's tempting to assume the first caused the second. The idea also offered a simple reason to fear any use at all.
What research shows: NIDA's summary covers both sides. Risk factors for cannabis use are similar to those for other drugs with addiction potential, which could explain part of the pattern. NIDA also says cannabis may cause brain changes that make addiction to other drugs more likely.
Its bottom line, though, is plain: most people who use or have used cannabis do not go on to use other substances later in life. Age matters here as well. Starting at a younger age raises the likelihood of developing a cannabis use disorder later on.
Verdict: Mostly a myth for adults. Cannabis isn't a dependable first step toward harder drugs, but early use and shared risk factors deserve attention.
Myth 3: "Everyone who uses cannabis gets hooked"
Where it came from: Two opposite myths circulate. Older anti-drug messages implied that any use leads to addiction, while a newer one says cannabis can't be addictive at all.
Why it stuck: Both versions match someone's experience. Plenty of adults use cannabis now and then without trouble, and some people find it genuinely hard to cut back.
What research shows: According to NIDA, studies estimate that 22% to 30% of people who use cannabis have cannabis use disorder. The strongest predictor is how often someone uses it, and starting younger raises the risk.
Clinicians diagnose cannabis use disorder against a set of criteria. NIDA's list includes using more than you meant to, trying and failing to cut back, cravings and continuing despite problems. Withdrawal, and needing more cannabis to get the same effect, are on the list too.
Help is available. NIDA notes that behavioral therapies, such as cognitive behavioral therapy, motivational enhancement therapy and contingency management, can be effective. There's no approved medication for the disorder yet. SAMHSA's National Helpline, 1-800-662-4357, offers referrals, and you can call or text 988 in a crisis.
Verdict: A myth in both directions. Most people who use cannabis don't develop a use disorder, but a meaningful share do, especially people who use often. If you're concerned about your own use, talk to a clinician.
Myth 4: "Cannabis makes people lazy"
Where it came from: The image of the unmotivated, couch-bound user is decades old. It even picked up a clinical-sounding label: "amotivational syndrome."
Why it stuck: Movies and TV have kept the character alive for generations. A familiar stereotype can feel like evidence, even when no one has measured it.
What research shows: A 2022 study from researchers at University College London and the University of Cambridge tested the stereotype directly. It compared 274 people in two age groups, adults aged 26 to 29 and teens aged 16 to 17. People who used cannabis one to seven days a week were compared with non-users matched by age and gender.
The team measured apathy, anhedonia (the loss of interest in pleasure), how much effort people would spend to earn a reward, and how much they wanted and enjoyed rewards. The cannabis users, who used about four days a week on average, didn't differ from non-users on apathy or effort. They actually reported slightly less anhedonia, and extra statistical checks backed up the lack of differences.
There are limits. Participants were tested when they weren't high, so the study can't speak to motivation mid-session. The researchers also called for more work with daily and near-daily users.
Verdict: Not supported for moderate use. Questions about heavy daily use remain open.
Myth 5: Indica relaxes, sativa energizes
Where it came from: The words echo old botanical names. Today, breeders, retailers and consumers use them to describe a plant's shape, aroma and expected effects.
Why it stuck: Two labels make a crowded menu easy to sort. The shorthand gets repeated on packaging and in conversation until it sounds like science.
What research shows: A 2021 study in the journal Nature Plants analyzed more than 100 cannabis samples. The researchers measured terpenes and cannabinoids and tested more than 100,000 genetic markers. Samples labeled indica and sativa were genetically indistinct across the genome.
The labels did line up with a small number of aroma compounds. The strongest link was with myrcene, an earthy terpene that tended to run higher in samples sold as indica. Samples sold as sativa leaned toward bergamotene and farnesene, terpenes with tea-like and fruity notes. Even so, the plants' genetic and chemical profiles together explained less than half of the variation in how they were labeled.
That's the heart of the indica vs. sativa myth. A label may hint at aroma, but it isn't a reliable guide to a plant's genetics, and it can't promise how a product will feel. Our indica vs. sativa guide explains what to compare instead.
Verdict: Unreliable as a way to predict effects. When you compare products, the THC and CBD numbers, the terpene information where it's listed and your own notes on past products tell you more.
What the evidence does support for using cannabis wisely
None of this means cannabis carries no risk. The research above points to a few practical habits for adults 21 and older:
- Go easy on potency. The strongest psychosis link in the 2019 study involved daily use of high-potency products. Our explainer on what counts as high THC puts label numbers in context.
- Keep frequency in check. How often you use is the strongest predictor of cannabis use disorder, so notice whether occasional use is drifting toward daily.
- Notice tolerance. Needing more to feel the same is on NIDA's list of use-disorder criteria. Take it as a signal to cut back, not a reason to go stronger.
- Pace yourself with edibles. Our roundup of common edible myths covers timing and dose.
- Talk to a clinician first if you're pregnant or breastfeeding, take medications, or have a personal or family history of psychosis.
- Never drive after using cannabis.
Potency myths deserve their own look, and our article on myths about strong weed sorts them out. For what studies suggest about cannabis and health, and where that evidence falls short, read our summary of the research on cannabis benefits.
If you'd like help comparing products by strength, our budtenders are happy to walk you through the labels at any of our Michigan locations.
